EDIT Editas Medicine, Inc.
EDIT Editas Medicine, Inc.
Healthcare · Biotechnology
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 bear converging
POC $2.72 · VWAP $2.77 · -15.2% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CEO, CFO + 1 other sold $19.1K, Sep 4
Coverage
2 watchlists
EDIT Price Structure
Loading timeframes…
Peers
Every watchlist EDIT belongs to, members best 30-day change first — EDIT highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@ibb
@biotech-scan
Reported EPS $-0.15 versus analyst consensus of $-0.28 (+46.2%).
full note →Against street estimates
How EDIT's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about EDIT from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 1 day ago · Oct 16
EDIT research tape
45 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.